Chapter 2 - The Audit Trail
"Talk to me, Frank," Daniel said, his voice dropping into the cold, surgical register he used during hostile takeovers.
"It’s worse than we thought," Frank’s voice crackled over the secure line. "I pulled the access logs for the Pier Forty-Seven cold storage locker. The security override code used to bypass the biometric scanner at 4:15 PM wasn't a hack. It belonged to an active administrative account."
"Whose?"
"A mid-level logistics supervisor named Kevin Vance," Frank said grimly. "And here’s where it gets interesting. Vance doesn't have the clearance to authorize pediatric biologics release. But three weeks ago, his clearance level was abruptly upgraded. Authorized by corporate human resources—specifically, an override signature from our internal compliance division."
Daniel’s eyes narrowed as he stared at the glowing monitor displaying Maya’s personnel file. "Who signed off on Vance’s clearance upgrade?"
"That’s the kicker," Frank muttered. "Ryan Callaway’s deputy, Marcus Cole. But Ryan swears he never approved it."
Daniel leaned back, the leather chair groaning under his weight. A corporate insider using compliance loopholes to siphon high-value medical supplies out of a secure port. It was textbook white-collar theft, but the merchandise wasn't microchips or luxury watches. It was life-saving medicine destined for children whose parents couldn't afford the predatory retail markups.
"Where is Kevin Vance right now?" Daniel asked, his fingers drumming a slow, steady tattoo against the polished mahogany.
"Nowhere near the pier," Frank replied. "Our tracking picked up his personal vehicle heading north toward an industrial warehouse district in Long Island City. We’ve got a team tailing him discreetly, but we need to know what your play is, Daniel. Do we call the NYPD, or do we handle this in-house?"
"If we involve the police right now, the paper trail gets buried in city bureaucracy, and the stolen biologics might get dumped or destroyed before we recover the batches earmarked for children like Maya's daughter," Daniel reasoned, his mind racing through the tactical variables. "We don't just want Vance. We want the distribution network behind him. Someone is buying these stolen shipments at a massive discount and reselling them through black-market pharmacy channels."
"And the pharmacy linked to Maya's prescription debt?" Frank asked sharply.
"That’s the distribution node," Daniel said, a cold realization dawning on him. "A closed-loop system. They artificially inflate the cost of critical medications at retail pharmacies, forcing desperate families into debt, while simultaneously stealing the same medications from our logistics supply chain to sell on the black market at a slightly lower—yet still extortionate—markup. They are profiting off both ends of human suffering."
"That’s sick," Frank whispered.
"It’s business," Daniel replied coldly, though the word tasted like ash in his mouth. "Track Vance to his destination. Don't move in until I give the word. I'm coming down there."
Daniel ended the call, stood up, and buttoned his suit jacket. As he walked out of his study toward the private exit, he passed the service kitchen.
The room was empty now. But on the pristine marble counter sat a single, sterilized baby bottle, filled not with milk, but with warm water, kept warm so the illusion of nourishment could comfort a six-year-old whose stomach was entirely empty.
Daniel felt a sharp, unfamiliar pang in his chest. He didn't pause. He grabbed his car keys and descended into the subterranean parking garage beneath the Tribeca building.
Forty minutes later, his black Aston Martin slipped quietly into the shadows of a decaying industrial park in Long Island City. Frank’s unmarked SUV was parked fifty yards down the wet asphalt, its hazard lights dark.
Daniel cut his headlights and slipped out into the biting autumn wind. He jogged over to Frank’s vehicle, pulling open the passenger door and sliding into the front seat.
"Status?" Daniel demanded, wiping rain from his face.
Frank pointed a gloved finger through the windshield toward a dilapidated brick warehouse bearing a faded sign that read Apex Medical Logistics.
"Vance pulled in twenty minutes ago," Frank whispered, handing Daniel a pair of military-grade night-vision binoculars. "Look at the loading bay doors. They aren't unloading normal cargo. They’re transferring crates into unmarked refrigerated vans—the exact same thermal specs as our missing pediatric biologics."
Daniel raised the binoculars, adjusting the focus against the gloom of the rainy night.
Through the green-tinted lenses, he saw Kevin Vance directing two burly men in heavy winter coats as they loaded aluminum transit cases into the back of a panel truck. And standing beside them, clipboard in hand, was a man Daniel recognized immediately.
Julian Thorne.
Daniel’s jaw tightened so hard a muscle feathered in his cheek.
Julian Thorne was a senior managing director at Sterling-Cross Capital—one of Daniel’s primary rival private equity firms, and a notorious corporate raider who specialized in distressed asset stripping and aggressive pharmaceutical buyouts.
"Sterling-Cross," Daniel murmured under his breath. "Thorne isn't just stealing medical supplies. He’s engineering supply chain shortages to artificially inflate the stock value of his own pharmaceutical portfolio, while simultaneously running a black-market distribution ring to bleed cash from uninsured families."
"It’s a monopoly play wrapped in a criminal cartel," Frank said, his voice hard. "What do you want to do, boss? We take them down now?"
May you like
Daniel looked at the warehouse, then thought back to the sound of Maya Santos crying behind a bathroom door over twenty-eight hundred dollars—money she didn't have because men like Julian Thorne treated human biology like a commodity to be traded and squeezed for maximum yield.
"No," Daniel said slowly, a dangerous, razor-sharp smile touching the corners of his lips. "We don't call the police yet. We document everything. And then, we pull the rug out from under them so hard they won't even know what hit the balance sheet."
